Ossiam Eli Lilly & CO Transaction History

Ossiam

$5.65 Billion
Q1 2024

A detailed history of Ossiam transactions in Eli Lilly & CO stock. As of the latest transaction made, Ossiam holds 90,675 shares of LLY stock, worth $82.1 Million. This represents 1.25% of its overall portfolio holdings.

Number of Shares

90,675

Previous 70,629 28.38%

Holding current value

$82.1 Million

Previous $41.2 Million 71.34%

% of portfolio

1.25%

Previous 0.67%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$592.2 - $792.28 $11.9 Million - $15.9 Million	20,046 Added 28.38%	90,675 $70.5 Million
Q4 2023 Feb 13, 2024	SELL	$525.19 - $619.13 $20.2 Million - $23.8 Million	-38,495 Reduced 35.28%	70,629 $41.2 Million
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $44.5 Million - $61.4 Million	-102,453 Reduced 48.42%	109,124 $58.6 Million
Q2 2023 Aug 11, 2023	BUY	$350.74 - $468.98 $29.5 Million - $39.4 Million	83,982 Added 65.82%	211,577 $99.2 Million
Q1 2023 May 12, 2023	BUY	$310.63 - $364.82 $17.1 Million - $20.1 Million	55,119 Added 76.05%	127,595 $43.8 Million

Q4 2022 Feb 13, 2023	BUY	$321.55 - $374.67 $21.1 Million - $24.6 Million	65,696 Added 968.97%	72,476 $26.5 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $1.97 Million - $2.25 Million	6,659 Added 5503.31%	6,780 $2.19 Million
Q2 2022 Aug 12, 2022	SELL	$278.73 - $327.27 $7.44 Million - $8.74 Million	-26,691 Reduced 99.55%	121 $39,000
Q1 2022 May 13, 2022	BUY	$234.69 - $291.66 $710,641 - $883,146	3,028 Added 12.73%	26,812 $7.68 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $283,086 - $351,311	1,259 Added 5.59%	23,784 $6.57 Million
Q3 2021 Nov 12, 2021	BUY	$221.6 - $272.71 $928,060 - $1.14 Million	4,188 Added 22.84%	22,525 $5.2 Million
Q2 2021 Aug 13, 2021	SELL	$180.55 - $233.54 $533,344 - $689,877	-2,954 Reduced 13.87%	18,337 $4.47 Million
Q1 2021 May 17, 2021	SELL	$164.32 - $212.72 $3.96 Million - $5.13 Million	-24,128 Reduced 53.12%	21,291 $3.98 Million
Q4 2020 Feb 12, 2021	BUY	$130.46 - $172.63 $5.78 Million - $7.65 Million	44,343 Added 4121.1%	45,419 $7.67 Million
Q3 2020 Nov 12, 2020	SELL	$146.22 - $169.13 $457,522 - $529,207	-3,129 Reduced 74.41%	1,076 $159,000
Q2 2020 Aug 13, 2020	SELL	$136.42 - $164.18 $468,193 - $563,465	-3,432 Reduced 44.94%	4,205 $690,000
Q1 2020 May 14, 2020	BUY	$119.05 - $147.35 $786,920 - $973,983	6,610 Added 643.62%	7,637 $1.06 Million
Q4 2019 Feb 14, 2020	SELL	$106.92 - $132.43 $2.78 Million - $3.44 Million	-25,978 Reduced 96.2%	1,027 $135,000
Q3 2019 Nov 13, 2019	BUY	$106.79 - $116.16 $2.81 Million - $3.06 Million	26,346 Added 3997.88%	27,005 $3.02 Million
Q2 2019 Aug 13, 2019	BUY	$110.79 - $129.32 $73,010 - $85,221	659 New	659 $73,000
Q1 2019 May 15, 2019	SELL	$111.31 - $131.02 $955,707 - $1.12 Million	-8,586 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$105.9 - $118.64 $909,257 - $1.02 Million	8,586 New	8,586 $994,000

Others Institutions Holding LLY

# of Institutions

3,719

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $860B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ossiam, based on Form 13F filings with the SEC.

News

Stay updated on Ossiam with notifications on news.

Account